Daniel Karlin
Chief Medical Officer at Definium Therapeutics Inc.
Sits on 1 board. Last updated September 30, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 month
- Director since
- 2026
1 month of board service in total across 1 board, counting each seat separately. Longest: Definium Therapeutics Inc., 1 month.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 25, 2026 | Definium Therapeutics Inc. | Open-market sale | −10,853 | $36.57 | $396,894 |
| Sep 14, 2026 | Definium Therapeutics Inc. | Grant or award | +200,000 | — | — |
| Aug 12, 2026 | Definium Therapeutics Inc. | Grant or award | +100,000 | — | — |
Questions about Daniel Karlin
What boards is Daniel Karlin on?
Daniel Karlin sits on the board of Definium Therapeutics Inc.
How long has Daniel Karlin served on boards?
Our records show at least 1 month of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.